Status:
COMPLETED
Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Kjaersgaard, Mimi, M.D.
Conditions:
Idiopathic Thrombocytopenic Purpura
Eligibility:
All Genders
1-14 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to describe the effect of anti-D on symptoms and platelet count in children suffering from unexplainable low platelet counts, when anti-D is administered as an injection u...
Detailed Description
Background: Idiopathic thrombocytopenic purpura (ITP) in children is considered a benign hematological disease. The incidence is approximately 50 cases a year in Denmark. Approximately 25 % will expe...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Idiopathic thrombocytopenic purpura (ITP)
Exclusion
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00128882
Start Date
November 1 2004
End Date
December 1 2008
Last Update
February 3 2009
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital, Department of Pediatrics
Aalborg, Denmark, 9100
2
Skejby Hospital, Aarhus University Hospital, Department of Pediatrics
Aarhus N, Denmark, 8200
3
Amager Hospital, Department of Pediatrics
Copenhagen S, Denmark, 2300
4
Rigshospitalet, Copenhagen University Hospital, Pediatric Clinic II
Copenhagen Ø, Denmark, 2100